Dexfin 50 Tablet ER
Marketer
Everen Healthcare
Salt Composition
Desvenlafaxine (50mg)
Overview Dexfin 50 Tablet ER
Sertraline extended-release 50mg tablets (Dexfin 50 Tablet ER equivalent) are a prescription medication indicated for major depressive disorder. This medication alleviates depression by elevating brain levels of serotonin and norepinephrine, neurotransmitters that promote calmness and nerve relaxation. Administered orally, Dexfin 50 Tablet ER may be taken with or without food, consistently at the same time daily for optimal blood concentration. If a dose is missed, take it as soon as recalled; avoid skipped doses and complete the prescribed course, even with symptom improvement. Abrupt cessation should be avoided; consult your physician before discontinuing treatment to prevent symptom exacerbation. Common side effects include nausea, vomiting, sleep disturbances (insomnia), and constipation. Blood pressure elevation, particularly during the initial month, warrants regular monitoring. Drowsiness and dizziness are possible; refrain from activities demanding concentration until the medication's effects are known. Report any unusual mood shifts to your doctor immediately, as they may indicate suicidal ideation.
Primary Ingredients of Dexfin 50 Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Dexfin 50 Tablet ER
Clinical depression
Major Benefits of Dexfin 50 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dexfin 50 Extended-Release Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dexfin 50 Tablet ER:
- Anxiety
- Constipation
- Decreased appetite
- Dizziness
- Increased sweating
- Insomnia (difficulty in sleeping)
- Nausea
- Sexual dysfunction
- Vomiting
How to use Dexfin 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dexfin 50 ER tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. While Dexfin 50 ER can be consumed with or without food, consistency in administration time is recommended.
How Dexfin 50 Tablet ER works:
Dexfin 50 Extended-Release tablets elevate brain levels of serotonin and norepinephrine, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Dexfin 50 Tablet ER and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Extended-release Dexfin 50mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dexfin 50mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Extended-release Dexfin 50mg tablets can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Dexfin 50 Extended-Release tablets to individuals with impaired renal function. Dosage modification of Dexfin 50 Extended-Release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Extended-release Dexfin 50 mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Dexfin 50 mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Dexfin 50 Tablet ER :
Should you forget a Dexfin 50 Tablet ER dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dexfin 50 Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Cyclohexanol Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |


